A Pilot Study to Establish a Standardized Protocol for Gene Microarray Analysis in Patients Receiving Neoadjuvant Chemotherapy for Breast Cancer: Identifying Factors Predictive of a Response to Paclitaxel.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Paclitaxel (Primary)
- Indications Breast cancer
- Focus Biomarker; Pharmacogenomic; Therapeutic Use
- 11 Jul 2018 Biomarkers information updated
- 26 Jun 2013 Planned end date changed from 1 Dec 2012 to 1 Dec 2014 as reported by ClinicalTrials.gov.
- 26 Jun 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.